Compounds > ro 31-8220
Page last updated: 2024-11-03

ro 31-8220 and Carcinoma, Anaplastic

ro 31-8220 has been researched along with Carcinoma, Anaplastic in 1 studies

Ro 31-8220: a protein kinase C inhibitor

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Flescher, E1
Rotem, R1

Other Studies

1 other study available for ro 31-8220 and Carcinoma, Anaplastic

ArticleYear
Protein kinase C epsilon mediates the induction of P-glycoprotein in LNCaP prostate carcinoma cells.
    Cellular signalling, 2002, Volume: 14, Issue:1

    Topics: Aspirin; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma; Diterpenes; Enzyme Inhi

2002